An interim analysis, scheduled to be conducted after 173 patients had died, allowed for elimination of one of the experimental treatments or discontinuation of the study for futility or for reporting treatment activity early in the
event of dramatic improvement in survival.Since the study was designed with futility rules, one-sided tests were specified for the alternative hypotheses, critical regions, and P values.